Quincy Bioscience is a research-based biotechnology company
Quincy Bioscience is a biotechnology company based in Madison, Wisconsin, that focuses on the discovery, development and commercialization of novel technologies to support cognitive function and other normal health challenges associated with aging.
Quincy Bioscience is set apart by its cutting-edge applications of apoaequorin which is breaking new ground with apoaequorin, originally discovered in jellyfish, now patented by Quincy Bioscience for use in a variety of products to support cognitive function. Apoaequorin is manufactured in a cGMP compliant facility.Read more...
The discovery and development of apoaequorin in 1962 earned the scientists responsible great acclaim. Quincy Bioscience is building on this work through its novel use of apoaequorin. Apoaequorin achieved self-affirmed GRAS status (generally recognized as safe) after an independent panel of expert scientists concluded that apoaequorin is safe for use in food products.
Prevagen® is the company's flagship consumer brand containing apoaequorin. A landmark double-blind and placebo-controlled trial demonstrated the ability to improve aspects of cognitive function in participants with either normal cognitive aging or very mild impairment, as determined by pre-trial screening. Prevagen is now the best-selling brain health supplement in chain pharmacies across America according to Nielsen data. See what real Prevagen users have to say.
Quincy Bioscience is a biotechnology company with its primary consumer product called Prevagen®, a dietary supplement designed to support brain health and to improve cognitive function. Currently Prevagen is the No. 1 selling brain health supplement per Nielsen data in chain pharmacies in the United States including distribution in Walgreens, Rite Aid and CVS stores in addition to placement in several thousand independent health food stores and pharmacies.
The main focus of Quincy is the discovery, development and commercialization of novel technologies to support cognitive function and other normal health challenges associated with aging.Read more...
A double-blind and placebo-controlled human clinical trial demonstrated a strong relationship with improvements in quantitative measures on cognitive function in subgroups with normal cognitive aging or mild impairment. This trial and other research on apoaequorin have been published in peer-reviewed journals and presented at various international neuroscience conferences.
Quincy Bioscience’s first headquarters building was located in the University Research Park in Madison, Wisconsin, in the fall of 2004. Simultaneously, a partnership was formed with the laboratory of Dr. James R. Moyer, Jr. of the University of Wisconsin at Milwaukee. Dr. Moyer is a leading expert in the field of memory and cognitive function.
Quincy Bioscience is only successful because of the great people that work here. Our team is composed of professionals from many different disciplines and works hard to serve the needs of our customers. Hard working, intelligent and thoughtful, our Associates keep striving to help others with their health needs through innovative products.